An anti-thrombotic sensor is also disclosed that comprises a coating of a complex of a non-heparin anti-thrombotic agent and an alkylbenzyldimethyl ammonium cationic salt.

Disclosed is a therapeutic agent for thrombosis, particularly a therapeutic agent for thrombosis effective with respect to both blood coagulation inhibition and thrombolysis.

A therapeutic agent for thrombosis comprising a pitavastatin and aspirin.

Certain of the compounds exhibit antithrombotic activity via direct, selective inhibition of thrombin, or are intermediates useful for forming compounds having antithrombotic activity.

The compounds of the above general formula (I) have useful pharmacological effects, in particular an anti-thrombotic effect and a factor Xa inhibiting effect.

The inventive compounds have an antithrombotic effect and are factor Xa inhibitors.

It exhibits 30% of the anticoagulant activity of heparin.

Venous thromboembolism and antithrombotic therapy in pregnancy

The compounds of the above general formula (I) has useful pharmacological properties, in particular an anti-thrombotic effect and a factor Xa inhibiting effect.

The outer cover provides a suitable surface for application of an antimicrobial/antithrombotic coating.

Local anesthetic, angioprotective, healing, antithrombotic, antiviral, decongestant.

The resulting coated surface is stable, anti-thrombotic and resistant to platelet adhesion.

They exhibit a good antithrombotic activity with a low pro-hemorrhagic risk.

Certain of the compounds exhibit antithrombotic activity via direct, selective inhibition of trombin.

Certain of the compounds exhibit antithrombotic activity via direct, selective inhibition of thrombin.